7Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infec -tive endocarditis: Utilization of specific endocardiographic findings : Duke endocarditis service [ J ]. Am J Med, 1994,96 : 200 - 209.
8Li W, Somerville J. Infective endocarditis in the grow -up congenital heart population[J]. Eur Heart J,1998,19(1): 166 -173.
9Hoen B. Epidemiology and antibiotic treatment of infective endocarditis : an update [ J ]. Heart ,2006,92 (11 ): 1 694 - 1 770.
10Winston LG, Bolger AF. Morden epidemiology, prophlaxis, and diagnosis and therapy for infective endocarditis[J]. Current Cardiology Reports,2006,8: 102 - 108.
2Hoen B. Epidemiology and antibiotic treatment o[ infective endo carditis：an update[J]. Heart, 2006,92(11) :1694 1770.
3Winston LG, Bolger AF. Morden epidemiology, prophlaxis, and di agnosis and therapy for infective endocarditis[J]. Curr Cardiol Rep,2006,8(2)：102 108.
4AI Dahouk S, Schneider T, Jansen A, et al. Brucella endocardi!is in prosthetic valves[J]. Can J Cardiol, 2006,22 ( 11 ) : 971-974.
5Shanson D. New guidelines and the development of an internation al consensus on recommendations for the antibiotic prophylaxis of infective endocarditis[J]. Int Health, 2010,2 ( 4 ) ： 231 238.
6Tleyjeh IM,Stecklberg JM, Murad HS,et a[. Temporal trends in infective endocarditis：a population based s：udy in Olinseed ('oun ty, Minnesota[J] J AMA, 2005,293 ( 24 ) : 3022 3028.
7Feder HM, Roberts JC, Salazar JC, et al. ttACIc.'K (mdocardilis in infants and children:two cases and a literature review[J]. Pediatr Inject Dis J ,Z003 ,Z2(6) 562.
8Katayama Y,Zhang HZ,Chambers HF. PBP 2a mutations produ cing very high level resistance to beta lactams[J] Antimicrob A gents Chemother,2004,48(2) :453-459.
9Rosenthal LB, Feja KN, Levasseur SM, et al. The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades[J]. Pediatric cardiology, 2010, 31 (6): 813-820.
10Ferrieri P,Gewitz MH,Gerber MA,et al. Unique features of infective endocarditis in childhood [ J ]. Pediatrics, 2002, 109 (5) :931-943.
